Neurocrine Biosciences Inc (NAS:NBIX)
$ 141.91 -0.09 (-0.06%) Market Cap: 14.28 Bil Enterprise Value: 13.59 Bil PE Ratio: 39.09 PB Ratio: 5.98 GF Score: 89/100

Q1 2020 Neurocrine Biosciences Inc Earnings Call Transcript

May 06, 2020 / 08:30PM GMT
Release Date Price: $103.48 (+1.67%)
Operator

Good day, everyone, and welcome to today's Neurocrine Biosciences Reports Q1 2020 Results Call. (Operator Instructions) Please note, this call may be recorded. I'll be standing by should you need assistance.

It is my pleasure to turn the program over to Kevin Gorman.

Kevin C. Gorman
Neurocrine Biosciences, Inc. - CEO & Director

Thank you very much, and good afternoon, everyone, and thank you for joining us today. Here with me at Neurocrine is Todd Tushla, our Head of Investor Relations; Matt Abernethy, our Chief Financial Officer; Eiry Roberts, our Chief Medical Officer; Eric Benevich, our Chief Commercial Officer; and Kyle Gano, our Chief Business Development Officer.

Before we get started, Todd, could you read our safe harbor statement, please?

Todd Tushla
Neurocrine Biosciences, Inc. - VP of IR

Yes. Good afternoon. Certain statements made in the course of this conference call that are not historical statements may be forward-looking statements, which are subject to risks and uncertainties

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot